US 11702389
Piperidine derivatives as HDAC1/2 inhibitors
granted A61PA61P35/00A61P35/02
Quick answer
US patent 11702389 (Piperidine derivatives as HDAC1/2 inhibitors) held by Regenacy Pharmaceuticals, Inc. expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regenacy Pharmaceuticals, Inc.
- Grant date
- Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P35/00, A61P35/02, A61P43/00, A61P7/00